federal_register: 2020-28714

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2020-28714 Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021 Notice The Food and Drug Administration (FDA) is announcing the fee rates under the Over-the-Counter (OTC) Monograph Drug user fee program for fiscal year (FY) 2021. On March 27, 2020, a new section was added to the Federal Food, Drug, and Cosmetic Act (FD&C Act) by the Coronavirus Aid, Relief, and Economic Security Act, which authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests. FDA refers to the OTC Monograph Drug user fee program as "OMUFA" throughout this document. This notice establishes the OMUFA fee rates for FY 2021. 2020-12-29 2020 12 https://www.federalregister.gov/documents/2020/12/29/2020-28714/fee-rates-under-the-over-the-counter-monograph-drug-user-fee-program-for-fiscal-year-2021 https://www.govinfo.gov/content/pkg/FR-2020-12-29/pdf/2020-28714.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the fee rates under the Over-the-Counter (OTC) Monograph Drug user fee program for fiscal year (FY) 2021. On March 27, 2020, a new section was added to the Federal Food, Drug, and Cosmetic Act (FD&C...

Links from other tables